LETTERS TO THE EDITOR
Reply to: Minimal detectable change and minimal clinically important differences in spinal muscular atrophy patients
First published: 12 March 2021
No abstract is available for this article.
CONFLICT OF INTEREST
B.S. received travel reimbursement and speaker honoraria from Biogen. C.K. received honoraria from Biogen and Roche. T.H. received honoraria from Novartis, Roche, and Biogen, and research support from Biogen, Roche, and AveXis.
Open Research
DATA AVAILABILITY STATEMENT
The data that support the findings of the original study are available on request from the corresponding author. The data are not publicly availabe due to privacy or ethical restrictions.
